Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Genetics

A type I interferon expression signature precedes T1DM

Nature Reviews Endocrinology volume 10, page 251 (2014)Cite this article

Subjects

Access through your institution
Buy or subscribe

Transient expression of a type I interferon (IFN)-inducible gene signature is a risk factor for autoimmunity in children genetically predisposed to develop type 1 diabetes mellitus (T1DM). Microarray analysis was used to define a set of 225 IFN-inducible genes, the expression of which was quantified in 87 healthy controls, 64 individuals with T1DM and 109 children predisposed to develop T1DM IFN-inducible gene expression was found to precede autoantibody development in the latter group, but not in individuals with established disease.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ferreira, R. C. et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes. Diabetes 10.2337/db13-1777

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A type I interferon expression signature precedes T1DM. Nat Rev Endocrinol 10, 251 (2014). https://doi.org/10.1038/nrendo.2014.33

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrendo.2014.33

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing